Pathology Grand Rounds - EGFR, Targeted Therapy and Resistance in Non-Small Cell Lung Carcinoma

At the conclusion of this activity, learners should be able to: * Understand the role of EGFR in lung cancer * Know the discovery of EGFR mutations in NSCLC * Recognize secondary and tertiary EGFR mutations * Distinguish small cell transformation * Introduce the pathology workflow for the EGFR-mutant NSCLC